Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All‐Cause Mortality
Key claim: Multimodal ageing biomarkers and plasma proteomic signatures are associated with all-cause mortality.
Abstract
Aging Cell, Volume 25, Issue 10, October 2026.
Why this matters
Head-to-head benchmarks within a single cohort are the only way to tell whether proteomic organ clocks add signal beyond established methylation clocks and routine physiologic measures. Here, organ-specific proteomic clocks predicted mortality but lost to GrimAge2 and simple multimodal measures (brain MRI, lung function, cognition), while a 368-protein signature anchored on the recurring GDF15/WFDC2/TIMP1 trio captured much of the proteomic mortality signal — suggesting composite organ-age derivations may not yet beat parsimonious single-protein or multimodal readouts.